Centiva Capital’s InFinT Acquisition Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per whole share IFIN.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-18,200
Closed -$1K 1930
2022
Q2
$1K Hold
18,200
﹤0.01% 1636
2022
Q1
$3K Buy
+18,200
New +$3.92K ﹤0.01% 1576

Other funds holding IFIN.WS

Centiva Capital's IFIN.WS Position: Q3 2022 in Review

Centiva Capital sold out of InFinT Acquisition Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per whole share (IFIN.WS) in Q3 2022, closing a stake of 18,200 shares — an estimated $1K sold.

Centiva Capital first reported a position in IFIN.WS in Q1 2022 and held it in 2 quarters. The position peaked at $3K in Q1 2022. 32 funds tracked by Wall St. Rank hold IFIN.WS as of Q3 2022.

  • Centiva Capital reported no remaining InFinT Acquisition Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per whole share position as of Q3 2022 after selling out during the quarter.
  • Centiva Capital sold 18,200 InFinT Acquisition Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per whole share shares in Q3 2022, an estimated $1K.
  • Centiva Capital first reported a position in InFinT Acquisition Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per whole share in Q1 2022 and held it in 2 quarters.
  • Centiva Capital's InFinT Acquisition Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per whole share position peaked at $3K in Q1 2022.
  • 32 funds tracked by Wall St. Rank held InFinT Acquisition Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per whole share as of Q3 2022.

Based on Centiva Capital's 13F filing for Q3 2022, filed 14 Nov 2022.